Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium chemoprevention in familial adenomatous polyposis (pilot study)
2022-000240-30Phase 2Completed
- Sponsor
- Center for Experimental and Molecular Medicine
- Start
- Apr 2022
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of lithium carbonate in Colonic Adenomatous Polyposis, sponsored by Center for Experimental and Molecular Medicine. Primary endpoint: NOTUM-positive crypt clone size and fixation. Started Apr 2022; status: completed.
02
Drugs
lithium carbonate
03
Conditions
Colonic Adenomatous Polyposis
Beyond the preview
Go deeper on 2022-000240-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000240-30.